Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

被引：2
|
作者：
El Kinge, Abdul Rahman
Hatourn, Hassan A.
Mahfouz, Rami A. [2 ]
Otrock, Zaher K. [2 ]
Jabbour, Elias [3 ]
Kantarjian, Hagop [3 ]
Bazarbachi, Ali [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期
关键词：
ACUTE MYELOGENOUS LEUKEMIA; RELAPSE; CHEMOTHERAPY; PROPOSAL;
D O I：
10.1016/j.leukres.2008.05.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [31] Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant - A pilot study
    Lipton, JH
    Messner, HA
    Curtis, JE
    Atkins, HL
    Minden, MD
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (01) : 42 - 45
  • [32] Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia
    Cai, Bo
    Wang, Yi
    Lei, Yangyang
    Shi, Yanping
    Sun, Qiyun
    Qiao, Jianhui
    Hu, Kaixun
    Lei, Yaqing
    Li, Bingxia
    Liu, Tieqiang
    Liu, Zhiqing
    Yao, Bo
    Zhao, Xuecong
    Li, Xiaofei
    Zhao, Wen
    Feng, Xiujie
    Xie, Anli
    Ning, Xin
    Feng, Mingxing
    Zhao, Weiwei
    Guo, Jiayue
    Ai, Huisheng
    Yu, Changlin
    Guo, Mei
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (11) : 1113 - 1122
  • [33] Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia
    Mamolo, Carla
    Welch, Verna
    Walter, Roland B.
    Cappelleri, Joseph C.
    Brockbank, James
    Cawson, Matthew
    Knight, Chris
    Wilson, Michele
    PHARMACOECONOMICS, 2021, 39 (01) : 121 - 131
  • [34] Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains
    Woods, Justin D.
    Zeidner, Joshua F.
    Van Deventer, Hendrik W.
    Jamieson, Katarzyna
    Matson, Melissa
    Zhang, Jack
    Pulley, William
    Brenizer, Tucker
    Muss, Hyman
    Nyrop, Kirsten A.
    Vohra, Sanah N.
    Deal, Allison M.
    Ivanova, Anastasia
    Foster, Matthew C.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (04) : 499 - 504
  • [35] A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
    Medeiros, Bruno C.
    Tanaka, Tiffany N.
    Balaian, Larisa
    Bashey, Asad
    Guzdar, Amy
    Li, Hongying
    Messer, Karen
    Ball, Edward D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05) : 346 - +
  • [36] Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years
    Cornelissen, J. J.
    Versluis, J.
    Passweg, J. R.
    van Putten, W. L. J.
    Manz, M. G.
    Maertens, J.
    Bverloo, H. B.
    Valk, P. J. M.
    Kooy, M. van Marwijk
    Wijermans, P. W.
    Schaafsma, M. R.
    Biemond, B. J.
    Vekemans, M-C
    Breems, D. A.
    Verdonck, L. F.
    Fey, M. F.
    Jongen-Lavrencic, M.
    Janssen, J. J. W. M.
    Huls, G.
    Kuball, J.
    Pabst, T.
    Graux, C.
    Schouten, H. C.
    Gratwohl, A.
    Vellenga, E.
    Ossenkoppele, G.
    Loewenberg, B.
    LEUKEMIA, 2015, 29 (05) : 1041 - 1050
  • [37] High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902
    Stone, Richard M.
    Moser, Barry
    Sanford, Ben
    Schulman, Philip
    Kolitz, Jonathan E.
    Allen, Steven
    Stock, Wendy
    Galinsky, Ilene
    Vij, Ravi
    Marcucci, Guido
    Hurd, David
    Larson, Richard A.
    LEUKEMIA RESEARCH, 2011, 35 (03) : 329 - 333
  • [38] Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?
    Min, Gi-June
    Cho, Byung-Sik
    Park, Sung-Soo
    Park, Silvia
    Jeon, Young-Woo
    Yahng, Seung-Ah
    Shin, Seung-Hawn
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    BLOOD RESEARCH, 2022, 57 (03) : 197 - 206
  • [39] Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia
    Pena Domingo, Marta
    Vives Polo, Susana
    Garrido Diaz, Ana
    Coll Jorda, Rosa
    Ribera Santasusana, J. M.
    Ferra Coll, Christelle
    MEDICINA CLINICA, 2020, 157 (07): : 325 - 328
  • [40] Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
    Jin Hayakawa
    Hideki Nakasone
    Daisuke Minakata
    Shin-ichiro Fujiwara
    Ayumi Gomyo
    Yu Akahoshi
    Yusuke Komiya
    Naonori Harada
    Tomotaka Ugai
    Kazuaki Kameda
    Hidenori Wada
    Yuko Ishihara
    Koji Kawamura
    Kana Sakamoto
    Miki Sato
    Kiriko Terasako-Saito
    Misato Kikuchi
    Shun-ichi Kimura
    Junya Kanda
    Shinichi Kako
    Yoshinobu Kanda
    International Journal of Hematology, 2022, 116 : 239 - 247
12345